|
44 Companies |
|
73 Products |
|
73 Products |
|
66 Mechanisms of Action |
|
11 Trials |
|
2460 News |
|
| «12...345678910111213...4950» |
- | amiodarone / Generic mfg.
New P2 trial: Enteramio: Evaluation of the Pharmacokinetic Profile, Pharmacodynamic Effects, Acceptability and Tolerability of an Oral Amiodarone Solution of 15 mg / mL in Children With Supra Ventricular Tachycardia (clinicaltrials.gov) - May 15, 2017
P2, N=0, Withdrawn, Sponsor: Centre Hospitalier Universitaire, Amiens
- | Enrollment change, Trial primary completion date: RCT for Women With a Persisting Pregnancy of Unknown Location (clinicaltrials.gov) - May 15, 2017
P=N/A, N=2, Terminated, Sponsor: University of Pennsylvania
N=450 --> 2 | Trial primary completion date: Apr 2015 --> Dec 2013
- || Trial primary completion date: Bleeding Events and Oral Anticoagulant Treatment in Non-Valvular Atrial Fibrillation (clinicaltrials.gov) - May 11, 2017
P=N/A, N=21300, Active, not recruiting, Sponsor: Bristol-Myers Squibb
N=450 --> 2 | Trial primary completion date: Apr 2015 --> Dec 2013 Trial primary completion date: Aug 2017 --> Aug 2018
- | amiodarone / Generic mfg.
Enrollment change, Trial withdrawal, Trial primary completion date: Anti-arrhythmic Medication v. MRI-Merge Ablation in the Treatment of Ventricular Tachycardia (clinicaltrials.gov) - May 10, 2017
P=N/A, N=0, Withdrawn, Sponsor: Johns Hopkins University
Trial primary completion date: Aug 2017 --> Aug 2018 N=70 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Aug 2012 --> Aug 2015
- ||| New trial: CLASS-AF: Clinical and Laboratory Predictors Associated With Stroke or Systemic Embolism in Low Risk Atrial Fibrillation Patients (clinicaltrials.gov) - May 10, 2017
P=N/A, N=1000, Recruiting, Sponsor: Korea University Guro Hospital
- | New P2 trial: VitC-AF: Vitamin C in Atrial Fibrillation Ablation (clinicaltrials.gov) - May 10, 2017
P2, N=20, Not yet recruiting, Sponsor: Virginia Commonwealth University
- | Trial primary completion date: FAST Mapping During Atrial Fibrillation (clinicaltrials.gov) - May 9, 2017
P=N/A, N=80, Recruiting, Sponsor: University Health Network, Toronto
N=70 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Aug 2012 --> Aug 2015 Trial primary completion date: Feb 2017 --> Dec 2017
- | warfarin / Generic mfg.
Biomarker, Trial completion, Phase classification, Enrollment change: Genotype-guided Warfarin Individualized Treatment (clinicaltrials.gov) - May 9, 2017
P4, N=660, Completed, Sponsor: The Third Xiangya Hospital of Central South University
Trial primary completion date: Feb 2017 --> Dec 2017 Recruiting --> Completed | Phase classification: P2 --> P4 | N=864 --> 660
- | Trial completion, Enrollment change: Preliminary Testing of the Vitaliti CVSM Wearable, Vitaliti Spirotoscope, and Vitaliti IVD Station (clinicaltrials.gov) - May 9, 2017
P=N/A, N=40, Completed, Sponsor: Cloud DX Inc.
Recruiting --> Completed | Phase classification: P2 --> P4 | N=864 --> 660 Enrolling by invitation --> Completed | N=13 --> 40
- | Trial completion: SD-CRYO-AF: Single Versus Double Cryoballoon Ablation for Pulmonary Vein Isolation in Patients With Atrial Fibrillation (clinicaltrials.gov) - May 9, 2017
P=N/A, N=140, Completed, Sponsor: Uppsala University Hospital
Enrolling by invitation --> Completed | N=13 --> 40 Active, not recruiting --> Completed
- || Enrollment status, HEOR: CATCH-AF: Catheter Ablation vs. Medical Therapy in Congested Hearts With AF (clinicaltrials.gov) - May 8, 2017
P4, N=220, Recruiting, Sponsor: Oussama Wazni
Active, not recruiting --> Completed Enrolling by invitation --> Recruiting
- ||| Trial completion: BIO.MASTER.BioMonitor 2 Study (clinicaltrials.gov) - May 8, 2017
P=N/A, N=92, Completed, Sponsor: Biotronik SE & Co. KG
Enrolling by invitation --> Recruiting Enrolling by invitation --> Completed
- | Enrollment open: STAR: Prospective Physician-Initiated Observational Study of The Contact Detection System (CDS) in Patients Undergoing Radiofrequency Ablation Using the Niobe (clinicaltrials.gov) - May 6, 2017
P=N/A, N=30, Recruiting, Sponsor: Erasmus Medical Center
Enrolling by invitation --> Completed Not yet recruiting --> Recruiting
- ||||| colchicine / Generic mfg.
Trial initiation date, Trial primary completion date: COPPER-AF: COlchicine for the Prevention of Post Electrical Cardioversion Recurrence of AF (clinicaltrials.gov) - May 5, 2017
P3, N=160, Not yet recruiting, Sponsor: Elpen Pharmaceutical Co. Inc.
Not yet recruiting --> Recruiting Initiation date: Dec 2016 --> Dec 2017 | Trial primary completion date: Feb 2017 --> Sep 2018
- | Trial primary completion date: REMI-2: Quantification of Endothelial Thrombogenicity in Patients With Atrial Fibrillation (clinicaltrials.gov) - May 5, 2017
P=N/A, N=200, Recruiting, Sponsor: Hospices Civils de Lyon
Initiation date: Dec 2016 --> Dec 2017 | Trial primary completion date: Feb 2017 --> Sep 2018 Trial primary completion date: Feb 2017 --> Feb 2018
- ||| New trial, HEOR: RE-QoL: Health-related Quality of Life in Patients on Anticoagulants (clinicaltrials.gov) - May 5, 2017
P=N/A, N=500, Recruiting, Sponsor: Boehringer Ingelheim
- | New P4 trial: Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation (clinicaltrials.gov) - May 4, 2017
P4, N=150, Recruiting, Sponsor: University of Michigan
- || Trial primary completion date: IMPACT-AFt: Clinical Trial to Improve Treatment With Blood Thinners in Patients With Atrial Fibrillation (clinicaltrials.gov) - May 3, 2017
P=N/A, N=2374, Active, not recruiting, Sponsor: Duke University
Trial primary completion date: Feb 2017 --> Feb 2018 Trial primary completion date: Jan 2017 --> Jun 2017
- Trial completion: MiFi-CTI: IntellaTip MiFi XP Ablation Catheter Trial (clinicaltrials.gov) - May 3, 2017
P=N/A, N=10, Completed, Sponsor: Boston Scientific Corporation
Trial primary completion date: Jan 2017 --> Jun 2017 Withheld --> Completed
- | warfarin / Generic mfg.
Trial primary completion date: Vitamin K Supplementation in Patients on Hemodialysis (clinicaltrials.gov) - May 3, 2017
P2, N=15, Recruiting, Sponsor: University Health Network, Toronto
Withheld --> Completed Trial primary completion date: Dec 2016 --> Dec 2018
- ||| Trial completion, Enrollment change: ImplemeNtation oF demOnstration pRoject for Health systeMs: Atrial Fibrillation (INFORM-AF) Part 1 (clinicaltrials.gov) - May 3, 2017
P=N/A, N=52, Completed, Sponsor: Duke University
Trial primary completion date: Dec 2016 --> Dec 2018 Recruiting --> Completed | N=110 --> 52
- | Enrollment change: Low Versus High Dose Magnesium Sulfate in the Early Management of Rapid Atrial Fibrillation (clinicaltrials.gov) - May 2, 2017
P3, N=450, Completed, Sponsor: University of Monastir
Recruiting --> Completed | N=110 --> 52 N=300 --> 450
- || dabigatran etexilate / Generic mfg.
Trial primary completion date: SPARK: Safety Study of Pradaxa in Atrial Fibrillation Patients by Regulatory Requirement of Korea (clinicaltrials.gov) - May 1, 2017
P=N/A, N=3000, Recruiting, Sponsor: Boehringer Ingelheim
N=300 --> 450 Trial primary completion date: Feb 2017 --> May 2017
- ||| carvedilol / Generic mfg., irbesartan / Generic mfg.
Trial completion, Combination therapy: Clinical Trial in Patients With Hypertension and Left Ventricular Dysfunction (clinicaltrials.gov) - May 1, 2017
P=N/A, N=100, Completed, Sponsor: Elpen Pharmaceutical Co. Inc.
Trial primary completion date: Feb 2017 --> May 2017 Recruiting --> Completed
- | warfarin / Generic mfg., apixaban / Generic mfg.
Trial completion: Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque (clinicaltrials.gov) - May 1, 2017
P4, N=64, Completed, Sponsor: Los Angeles Biomedical Research Institute
Recruiting --> Completed Active, not recruiting --> Completed
- | Enrollment change, Trial withdrawal, Trial primary completion date: Testing the Accuracy of a Personal Heart Rhythm Monitor to Detect Prolonged Paroxysmal Atrial Fibrillation (clinicaltrials.gov) - Apr 26, 2017
P3, N=0, Withdrawn, Sponsor: University of Surrey
Active, not recruiting --> Completed N=30 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Oct 2014 --> Oct 2015
- | Biomarker, Trial completion, Enrollment change, Trial primary completion date: Using a Personal Heart Rhythm Monitor to Diagnose Paroxsymal Atrial Fibrillation in the Community (clinicaltrials.gov) - Apr 26, 2017
P3, N=194, Completed, Sponsor: University of Surrey
N=30 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Oct 2014 --> Oct 2015 Recruiting --> Completed | N=900 --> 194 | Trial primary completion date: Oct 2014 --> Aug 2015
- | Trial completion: TCAI_APPROVAL: Impact Of Different Ablation Approaches on Outcome In Coexistent Atrial Fibrillation and Flutter (clinicaltrials.gov) - Apr 26, 2017
P3, N=86, Completed, Sponsor: Texas Cardiac Arrhythmia Research Foundation
Recruiting --> Completed | N=900 --> 194 | Trial primary completion date: Oct 2014 --> Aug 2015 Active, not recruiting --> Completed
- | Trial completion: TCAI_BELIEF: Effect of Empirical Left Atrial Appendage Isolation on Long-term Procedure Outcome in Patients With Persistent or Long-standing Persistent Atrial Fibrillation Undergoing Catheter Ablation (clinicaltrials.gov) - Apr 26, 2017
P3, N=156, Completed, Sponsor: Texas Cardiac Arrhythmia Research Foundation
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Surgery: AFACT: Atrial Fibrillation Ablation and Autonomic Modulation Via Thorascopic Surgery (clinicaltrials.gov) - Apr 25, 2017
P4, N=240, Completed, Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Active, not recruiting --> Completed Recruiting --> Completed
- | Trial completion, Trial primary completion date: Therapeutic Outcomes Using Contact Force Handling During Atrial Fibrillation Ablation (clinicaltrials.gov) - Apr 25, 2017
P=N/A, N=120, Completed, Sponsor: Southlake Regional Health Centre
Recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Jun 2015 --> Feb 2017
- | Trial completion, Enrollment change, Trial primary completion date: Clinical Benefits of Additional Complex Fractionated Atrial Electrogram Targeted Catheter Ablation for Longstanding Persistent Atrial Fibrillation (clinicaltrials.gov) - Apr 25, 2017
P=N/A, N=40, Completed, Sponsor: Yonsei University
Recruiting --> Completed | Trial primary completion date: Jun 2015 --> Feb 2017 Recruiting --> Completed | N=220 --> 40 | Trial primary completion date: Jun 2024 --> Feb 2017
- | New trial: A.Fib Emergency Department Study Atrial Fibrillation (clinicaltrials.gov) - Apr 25, 2017
P=N/A, N=778, Recruiting, Sponsor: Queen's University
- | Trial completion, Phase classification: Foresight Intracardiac Echocardiography (ICE) System (clinicaltrials.gov) - Apr 24, 2017
P, N=10, Completed, Sponsor: Conavi
Recruiting --> Completed | N=220 --> 40 | Trial primary completion date: Jun 2024 --> Feb 2017 Recruiting --> Completed | Phase classification: PN/A --> P
- | New trial: Development of a Questionnaire to Assess Patient Knowledge About Non-vitamin K Anticoagulants (NOAC) (clinicaltrials.gov) - Apr 24, 2017
P=N/A, N=30, Recruiting, Sponsor: University Hospital, Basel, Switzerland
- | Trial primary completion date: Patient Perceptions and Physician Assessment of Benefits and Risks of Oral Anticoagulation Due to Non-valvular AF (clinicaltrials.gov) - Apr 21, 2017
P=N/A, N=91, Active, not recruiting, Sponsor: Medical University of Graz
Recruiting --> Completed | Phase classification: PN/A --> P Trial primary completion date: Feb 2017 --> Oct 2017
- ||| New trial: Clinical Investigation of the LAmbre Left Atrial Appendage Closure System (clinicaltrials.gov) - Apr 20, 2017
P=N/A, N=61, Completed, Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd.
- ||||||| amiodarone / Generic mfg.
Trial completion: Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia (clinicaltrials.gov) - Apr 17, 2017
P3, N=3024, Completed, Sponsor: University of Washington
Trial primary completion date: Feb 2017 --> Oct 2017 Active, not recruiting --> Completed
- | Phase classification: Leader - Evaluation of Endotak Reliance (clinicaltrials.gov) - Apr 14, 2017
P=N/A, N=904, Completed, Sponsor: Boston Scientific Corporation
Active, not recruiting --> Completed Phase classification: P4 --> P=N/A
- || Enrollment closed: TRUE-HD: Prospective Registry on User Experience With The Mapping System For Ablation Procedures (clinicaltrials.gov) - Apr 14, 2017
P=N/A, N=577, Active, not recruiting, Sponsor: Boston Scientific Corporation
Phase classification: P4 --> P=N/A Recruiting --> Active, not recruiting
- | Trial completion: Safebeat: Influence of Sleep Apnea on Risk of Atrial Fibrillation (clinicaltrials.gov) - Apr 14, 2017
P=N/A, N=317, Completed, Sponsor: The Cleveland Clinic
Recruiting --> Active, not recruiting Recruiting --> Completed
- ||| apixaban / Generic mfg.
Enrollment closed: AXAFA: Apixaban During Atrial Fibrillation Catheter Ablation: Comparison to Vitamin K Antagonist Therapy (clinicaltrials.gov) - Apr 13, 2017
P4, N=663, Active, not recruiting, Sponsor: German Atrial Fibrillation Network
Recruiting --> Completed Recruiting --> Active, not recruiting
- | Trial completion, Enrollment change: Effects of Chronic Antihypertensive Therapy on Clinical Outcomes in Septic Shock (clinicaltrials.gov) - Apr 13, 2017
P=N/A, N=133, Completed, Sponsor: Rush University Medical Center
Recruiting --> Active, not recruiting Active, not recruiting --> Completed | N=200 --> 133
- Enrollment open: 2016-IMR: Cardiovascular Magnetic Resonance-Guided Radiofrequency-Ablation for Atrial Flutter II (clinicaltrials.gov) - Apr 12, 2017
P=N/A, N=35, Recruiting, Sponsor: Heartcenter Leipzig GmbH
Active, not recruiting --> Completed | N=200 --> 133 Not yet recruiting --> Recruiting
- | Phase classification: SULTAN: Subtherapeutic INR Levels in Patients With AVK: Incidence, Associated Factors, Prognosis and Control Strategies (clinicaltrials.gov) - Apr 12, 2017
P=N/A, N=1022, Active, not recruiting, Sponsor: Bayer
Not yet recruiting --> Recruiting Phase classification: P4 --> P=N/A
- | Trial completion, Trial primary completion date, Combination therapy: TATRC: Validation of the NTX Wireless Patient Monitoring System (clinicaltrials.gov) - Apr 11, 2017
P=N/A, N=1303, Completed, Sponsor: Vanderbilt University Medical Center
Phase classification: P4 --> P=N/A Enrolling by invitation --> Completed | Trial primary completion date: Feb 2009 --> Jan 2010
- ||| Trial completion, Trial primary completion date: CARMEN-AF: Registry of Atrial Fibrillation and Embolic Risk in Mexico (clinicaltrials.gov) - Apr 11, 2017
P=N/A, N=1200, Completed, Sponsor: Registro de Fibrilaci
Enrolling by invitation --> Completed | Trial primary completion date: Feb 2009 --> Jan 2010 Enrolling by invitation --> Completed | Trial primary completion date: Dec 2015 --> Dec 2016
- | Trial completion: LAGO-FA: Left Atrial Geometry and Outcomes After Atrial Fibrillation Ablation (clinicaltrials.gov) - Apr 11, 2017
P=N/A, N=417, Completed, Sponsor: Hospital Clinic of Barcelona
Enrolling by invitation --> Completed | Trial primary completion date: Dec 2015 --> Dec 2016 Active, not recruiting --> Completed
- | Phase classification: Safety and Efficacy of CryoCor (clinicaltrials.gov) - Apr 10, 2017
P=N/A, N=174, Completed, Sponsor: Boston Scientific Corporation
Active, not recruiting --> Completed Phase classification: P3 --> P=N/A
- ||| Trial completion: Evaluation of Pacemaker Algorithms to Avoid Unnecessary Right Ventricular Pacing (clinicaltrials.gov) - Apr 10, 2017
P=N/A, N=70, Completed, Sponsor: Deutsches Herzzentrum Muenchen
Phase classification: P3 --> P=N/A Active, not recruiting --> Completed